Artemis Medicare [ARTEMISMED] vs A [AAL] Detailed Stock Comparison

Artemis Medicare

NSE

A

BSE

TLDR: Quick Comparison Summary

We found some data (2 metrics), but not enough for a complete comparison. Metrics like P/E ratio, profitability, and financial health are still available in the detailed tabs below.

View Metrics Details

Vital Metrics Comparison

Note: Limited metrics are available for comparison. Check other tabs for more detailed analysis.

Metric	Artemis Medicare	A	Better
P/E Ratio (TTM)	105.14	N/A	N/A
Price-to-Book Ratio	3.96	N/A	N/A
Debt-to-Equity Ratio	34.41	N/A	N/A
EV/EBITDA	21.66	N/A	N/A
Profit Margin (TTM)	9.01%	N/A	N/A
Operating Margin (TTM)	11.86%	N/A	N/A
EBITDA Margin (TTM)	11.86%	N/A	N/A
Dividend Yield	0.18%	N/A	N/A
1-Year Return	-13.38%	94.18%	A
Enterprise Value	$32.46B	$0	Artemis Medicare
EV/Revenue Ratio	3.35	N/A	N/A
Revenue per Share (TTM)	$62	N/A	N/A
Earnings per Share (Diluted)	$2.29	N/A	N/A
Beta (Stock Volatility)	0.26	N/A	N/A

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Artemis Medicare vs A Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Artemis Medicare	0.32%	0.04%	-1.98%	-2.94%	-11.72%	-24.18%
A	-1.06%	0.95%	1.76%	22.90%	52.06%	64.89%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Artemis Medicare	-13.38%	315.89%	550.95%	6.11%	6.11%	6.11%
A	94.18%	110.50%	947.51%	1,029.53%	1,029.53%	1,029.53%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Artemis Medicare (ARTEMISMED): View Full Stock Overview

A (AAL): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Artemis Medicare vs A

Metric	ARTEMISMED	AAL
Market Information
Market Cap i	₹0	₹0
Market Cap Category	Micro cap	Micro cap
10 Day Avg. Volume i	102,765	39,415
90 Day Avg. Volume i	93,862	43,665
Last Close	₹239.48	₹656.55
52 Week Range	₹207.71 - ₹350.00	₹290.35 - ₹679.50
% from 52W High	-31.58%	-3.38%
All-Time High	₹350.00 (Dec 16, 2024)	₹679.50 (Aug 06, 2025)
% from All-Time High	-31.58%	-3.38%
Growth Metrics
Quarterly Revenue Growth	0.14%	N/A
Quarterly Earnings Growth	0.28%	N/A
Financial Health
Profit Margin (TTM) i	0.09%	N/A
Operating Margin (TTM) i	0.12%	N/A
Return on Equity (TTM) i	N/A	N/A
Debt to Equity (MRQ) i	34.41	N/A
Cash & Liquidity
Book Value per Share (MRQ)	₹60.88	N/A
Cash per Share (MRQ)	₹28.45	N/A
Operating Cash Flow (TTM) i	₹0	₹0
Levered Free Cash Flow (TTM) i	₹0	₹0
Dividends
Last 12-Month Dividend Yield i	0.18%	N/A
Last 12-Month Dividend i	₹0.45	N/A

Valuation & Enterprise Metrics Analysis: Artemis Medicare vs A

Metric	ARTEMISMED	AAL
Price Ratios
P/E Ratio (TTM) i	105.14	N/A
Forward P/E i	25.25	N/A
PEG Ratio i	N/A	N/A
Price to Sales (TTM) i	N/A	N/A
Price to Book (MRQ) i	3.96	N/A
Market Capitalization
Market Capitalization i	₹0	₹0
Enterprise Value i	₹32.46B	₹0
Enterprise Value Metrics
Enterprise to Revenue i	3.35	N/A
Enterprise to EBITDA i	21.66	N/A
Risk & Other Metrics
Beta i	0.26	N/A
Book Value per Share (MRQ) i	₹60.88	N/A

Financial Statements Comparison: Artemis Medicare vs A

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	ARTEMISMED	AAL
Revenue/Sales i	N/A	N/A
Cost of Goods Sold i	N/A	N/A
Gross Profit i	N/A	N/A
Research & Development i	N/A	N/A
Operating Income (EBIT) i	N/A	N/A
EBITDA i	N/A	N/A
Pre-Tax Income i	N/A	N/A
Income Tax i	N/A	N/A
Net Income (Profit) i	N/A	N/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	ARTEMISMED	AAL
Cash & Equivalents i	N/A	N/A
Total Current Assets i	N/A	N/A
Total Current Liabilities i	N/A	N/A
Long-Term Debt i	N/A	N/A
Total Shareholders Equity i	N/A	N/A
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	N/A	N/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	ARTEMISMED	AAL
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	ARTEMISMED	AAL
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	102,765	39,415
Average Daily Volume (90 Day) i	93,862	43,665
Shares Outstanding i	N/A	N/A
Float Shares i	25.20M	N/A
% Held by Insiders i	0.78%	N/A
% Held by Institutions i	0.02%	N/A

Dividend Analysis & Yield Comparison: Artemis Medicare vs A

Metric	ARTEMISMED	AAL
Last 12-Month Dividend i	₹0.45	N/A
Last 12-Month Dividend Yield i	0.18%	N/A
3-Year Avg Annual Dividend i	₹0.45	N/A
3-Year Avg Dividend Yield i	0.25%	N/A
3-Year Total Dividends i	₹1.35	N/A
Ex-Dividend Date	Jul 11, 2025	N/A

Artemis Medicare [ARTEMISMED] vs A [AAL] Detailed Stock Comparison